Concepedia

Publication | Open Access

Nonclinical Evaluation of PF-06438179: A Potential Biosimilar to Remicade® (Infliximab)

36

Citations

5

References

2016

Year

Abstract

Pfizer Inc.

References

YearCitations

Page 1